simvastatin has been researched along with Child Behavior Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catsman-Berrevoets, CE; de Wit, MC; Descheemaeker, MJ; Elgersma, Y; Legius, E; Moll, HA; Oostenbrink, R; Plasschaert, E; Renard, M; Rietman, AB; van der Vaart, T; Vergouwe, Y; Vogels, A | 1 |
| Acosta, MT | 1 |
| Forget, PP; Rubio-Gozalbo, ME; Spaapen, LJ; van Waardenburg, DA; Verrips, A; Vroomen, PC | 1 |
1 trial(s) available for simvastatin and Child Behavior Disorders
| Article | Year |
|---|---|
Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.
Topics: Adolescent; Child; Child Behavior Disorders; Cognition Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neurofibromatosis 1; Placebos; Simvastatin; Time Factors; Treatment Outcome | 2013 |
2 other study(ies) available for simvastatin and Child Behavior Disorders
| Article | Year |
|---|---|
Challenges of cognitive research in neurofibromatosis type 1.
Topics: Child Behavior Disorders; Cognition Disorders; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neurofibromatosis 1; Simvastatin | 2013 |
Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Antipsychotic Agents; Child; Child Behavior Disorders; Clopenthixol; Humans; Male; Neuroleptic Malignant Syndrome; Simvastatin | 2001 |